BOQI International Medical logo
BOQI International Medical BIMI

Quarterly report 2023-Q3
added 12-19-2023

report update icon

BOQI International Medical Cost of Revenue 2011-2025 | BIMI

Cost of Revenue is a financial metric that reflects all direct costs associated with the production of goods or the provision of services that directly led to revenue during the reporting period. It is the total amount of expenses incurred by the company to deliver its products or services, including both production costs and related expenses necessary for delivery or customer support.
What is included in the cost of revenue
Cost CategoryExamples
Production CostsMaterials, wages of production staff, depreciation of equipment
Service and SupportCustomer service, user support, technical assistance
Delivery and LogisticsPackaging, delivery of goods to customers
Hosting and InfrastructureServers, cloud platforms (especially for IT and SaaS companies)
Content and LicensesLicense purchases, production royalties (e.g., in streaming services)

Importance of the Metric
  • Helps to understand how costly the revenue-generating process is.
  • A high cost of revenue may indicate:
    Poor cost control
    Low operational efficiency
  • A low cost of revenue combined with high revenue indicates high profitability and business competitiveness.

Annual Cost of Revenue BOQI International Medical

2022 2021 2020 2019 2018 2017 2016 2015 2014 2013 2012 2011
9.88 M 18.9 M 10.4 M 304 K 6.08 M 7.59 M 5.89 M 5.54 M 8.5 M 4.13 M 7.42 M 10.8 M

All numbers in USD currency

Indicator range from annual reports

Maximum Minimum Average
18.9 M 304 K 7.95 M

Quarterly Cost of Revenue BOQI International Medical

2023-Q3 2023-Q2 2023-Q1 2022-Q4 2022-Q3 2022-Q2 2022-Q1 2021-Q4 2021-Q3 2021-Q2 2021-Q1 2020-Q4 2020-Q3 2020-Q2 2020-Q1 2019-Q4 2019-Q3 2019-Q2 2019-Q1 2018-Q4 2018-Q3 2018-Q2 2018-Q1 2017-Q4 2017-Q3 2017-Q2 2017-Q1 2016-Q4 2016-Q3 2016-Q2 2016-Q1 2015-Q4 2015-Q3 2015-Q2 2015-Q1 2014-Q4 2014-Q3 2014-Q2 2014-Q1 2013-Q4 2013-Q3 2013-Q2 2013-Q1 2012-Q4 2012-Q3 2012-Q2 2012-Q1 2011-Q4 2011-Q3 2011-Q2 2011-Q1
2.41 M 2.67 M 1.51 M - 4.23 M 2.36 M 2.34 M - 11.7 M 7.29 M 1.58 M - 2.83 M 3.07 M 332 K - 281 K 319 K 431 K - 957 K 273 K 116 K - 1.1 M 1.38 M 910 K - 1.54 M 626 K 1.71 M - 2.25 M 963 K 895 K - 2.06 M 1.49 M 1.34 M - 914 K 1.04 M 888 K - 1.45 M 2.79 M 778 K - 2.1 M 3.76 M 1.82 M

All numbers in USD currency

Indicator range from quarterly reporting

Maximum Minimum Average
11.7 M 116 K 1.96 M

Cost of Revenue of other stocks in the Pharmaceutical retailers industry

Issuer Cost of Revenue Price % 24h Market Cap Country
Trxade Group Trxade Group
MEDS
5.67 M - 4.55 % $ 5.8 M usaUSA
Greenlane Holdings Greenlane Holdings
GNLN
112 M $ 2.99 -3.24 % $ 22.5 M usaUSA
PetMed Express PetMed Express
PETS
158 M $ 3.02 70.69 % $ 62.2 M usaUSA
LifeMD LifeMD
LFMD
18.9 M $ 3.45 -4.43 % $ 117 M usaUSA
Rite Aid Corporation Rite Aid Corporation
RAD
19.3 B - - $ 35.5 M usaUSA
111 111
YI
11.8 B $ 3.7 -4.15 % $ 636 M chinaChina
Walgreens Boots Alliance Walgreens Boots Alliance
WBA
121 B - - $ 10.3 B usaUSA